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Cyclic dinucleotides (CDNs) play key roles as second
messengers and signaling molecules in bacteria
and metazoans. The newly identified dinucleotide
cyclase in Vibrio cholerae (DncV) produces three
different CDNs containing two 30–50 phosphodiester
bonds, and its predominant product is cyclic GMP-
AMP, whereas mammalian cyclic GMP-AMP syn-
thase (cGAS) produces only cyclic GMP-AMP con-
tainingmixed 20–50 phosphodiester bonds. We report
the crystal structures of V. cholerae and Escherichia
coli DncV in complex with various nucleotides in the
pre-reaction states. The high-resolution structures
revealed that DncV preferably recognizes ATP and
GTP as acceptor and donor nucleotides, respec-
tively, in the first nucleotidyl transfer reaction.
Considering the recently reported intermediate
structures, our pre-reaction state structures pro-
vide the precise mechanism of 30–50 linked cyclic
AMP-GMP production in bacteria. A comparison
with cGAS in the pre-reaction states suggests that
the orientation of the acceptor nucleotide primarily
determines the distinct linkage specificities between
DncV and cGAS.
INTRODUCTION
Cyclic dinucleotides (CDNs) are small molecules composed of
two nucleotides linked via two phosphodiester bonds and they
play important roles as second messengers in both bacterial
and mammalian cells (Danilchanka and Mekalanos, 2013). In
Gram-negative bacteria, cyclic di-GMP works as an important
regulatory factor in many cellular functions, including flagellum
biosynthesis, biofilm formation, virulence, and infectivity (Ro¨m-
ling et al., 2013). Likewise, cyclic di-AMP is indispensable
for the survival of Gram-positive bacteria by regulating physio-
logical functions, such as sporulation, cell wall biosynthesis,
and cell morphology (Corrigan and Gru¨ndling, 2013). A new
type of CDN, termed cyclic GMP-AMP (cGAMP), was first iden-
tified in Vibrio cholerae seventh pandemic strains, and was
shown to be involved in its virulence (Davies et al., 2012). This
CDN molecule contains two 30–50 phosphodiester bonds (cyclicStructure 23G(30,50)pA(30,50)p; 30–50 cGAMP) and is synthesized by the DncV
dinucleotide cyclase. DncV can also synthesize cyclic di-GMP
and cyclic di-AMP, using GTP and ATP as the sole substrates,
respectively. Overexpression of DncV suppresses the chemo-
taxis of V. cholerae and facilitates intestinal colonization, result-
ing in hyperinfectivity. Genome analyses predicted the presence
of DncV orthologs in various Gram-positive and -negative bacte-
ria, implying that cGAMP also works as a signaling molecule
in other bacterial species. Recently, a hybrid CDN composed
of AMP and GMP was discovered in mammalian cells as one
of the triggering factors for the innate immune response
(Wu et al., 2013). This cGAMP molecule is synthesized by the
enzyme cyclic GMP-AMP synthase (cGAS), in response to cyto-
solic DNA, resulting in the stimulation of the adaptor protein
STING, followed by the activation of the IRF3-interferon b axis
(Sun et al., 2013). Based on their primary sequences, both
DncV and cGAS are classified as nucleotidyl transferase super-
family members, although they share very weak homology.
In general, this enzyme family catalyzes a nucleotidyl transfer
reaction such as DNA and RNA polymerase and transfers a
50-triphosphate of donor nucleotide to the 20-OH or 30-OH of
an acceptor nucleotide (Hornung et al., 2014). Biochemical
studies revealed that cGAMP in mammals contains one 30–50
phosphodiester bond and one non-canonical 20–50 phospho-
diester bond (cyclic G(20,50)pA(30,50)p; 20–50 cGAMP) (Ablasser
et al., 2013; Davies et al., 2012; Diner et al., 2013). Structural
studies showed that mammalian cGAS has two nucleotide
pockets, i.e., acceptor and donor pockets, and catalyzes two
sequential reactions in one active site (Civril et al., 2013; Gao
et al., 2013; Li et al., 2013; Hornung et al., 2014). In the first
reaction, the 20–50 phosphodiester linkage is formed between
GTP and ATP bound to the acceptor and donor pockets, respec-
tively, thereby producing a pppG(20,50)pAmolecule. This product
then flips and rebinds to the catalytic pocket in the reverse
direction. In the second reaction, the intramolecular 30–50 phos-
phodiester linkage in the pppG(20,50)pA molecule is formed to
produce 20–50 cGAMP.
In contrast tomammalian cGAS, DncV is a constitutively active
enzyme and can produce three different types of CDNs (i.e., 30–50
cGAMP, c-di-GMP, and c-di-AMP) in the absence of bound
DNA (Davies et al., 2012; Diner et al., 2013). However, when
GTP and ATP are used as substrates in vitro, the predominant
product of DncV is 30–50 cGAMP. Similarly, the major product
of DncV in vivo, where both GTP and ATP are present, was
also shown to be 30–50 cGAMP (Davies et al., 2012; Diner et al.,
2013). Quite recently, the crystal structures of V. cholerae, 843–850, May 5, 2015 ª2015 Elsevier Ltd All rights reserved 843
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Figure 1. Overall Architecture of Bacterial DncV
(A) Crystal structure of VcDncV in the GTP-bound form shown as a ribbon representation. The a helices and b sheets are colored beige and green, respectively.
The spine and the catalytic loop are colored blue and pink, respectively. The catalytic triad is shown as a green stick. The boundmagnesium ions and nucleotides
are shown as dark gray spheres and yellow sticks, respectively.
(B) Crystal structure of EcDncV in the 30-dGTP-bound form with the same representation as in (A).DncV (VcDncV) were reported from two groups independently.
Zhu et al. (2014) determined the structure of VcDncV with
5-methyltetrahydrofolate diglutamate, a folate analog, and
revealed the mechanism of the catalytic activity regulation
by folates. Kranzusch et al. (2014) determined the structures of
VcDncV in the apo GTP analog (guanosine-50-(a, b)-methyleno
triphosphate, GMPCPP)-bound and pppA(30–50)pG-bound
forms. The GMPCPP-bound form is considered to be a state
before the first reaction step (pre-reaction state), while the
pppA(30–50)pG-bound form is regarded as a state before
the second reaction step (intermediate state). Analyses of
these structures suggested that DncV produces 30–50 cGAMP
in a similar manner to cGAS, except that its acceptor and donor
pockets bind to ATP and GTP, respectively, to form pppA(30–50)
pG as the product of the first reaction step. Moreover, based on
a structural comparison between VcDncV and mouse cGAS
in the intermediate state, it was proposed that Ile376 (Arg376
in human cGAS) is critical for their distinct linkage specificities,
i.e., 20–50 versus 30–50 (Kranzusch et al., 2014). However, the
substrate recognition mechanism in the pre-reaction state,
which defines the 30–50 phosphodiester linkage specificity, still
remains elusive because the electron density for the acceptor
nucleotide was not observed in the pre-reaction state.
Here, we report the crystal structures of VcDncV in the apo,
two GTP-bound, and two 30-deoxy ATP (30-dATP)-bound forms,
and the Escherichia coli DncV (EcDncV) homolog in the 30-deoxy
GTP (30-dGTP)-bound form. Our high-resolution structures
revealed the manner of GTP and ATP recognition in the pre-
reaction state, explaining why DncV can produce c-di-GMP
and c-di-AMP, as well as 30–50 cGAMP. A structural comparison
between VcDncV and porcine cGAS suggested that the orien-844 Structure 23, 843–850, May 5, 2015 ª2015 Elsevier Ltd All rightstation of the acceptor nucleotide in the pre-reaction state is a
major determinant for the distinct linkage specificities between
DncV and cGAS.
RESULTS AND DISCUSSION
Structure Determination
We determined the crystal structure of VcDncV at 1.77 A˚ resolu-
tion by the single-wavelength anomalous diffraction method,
using selenomethionine (SeMet)-labeled protein. To obtain the
crystals, we deleted the C-terminal region, which was predicted
to be disordered (residues 413–436) and replaced the less-
conserved region (residues 216–241) with a three-residue (Gly-
Ser-Gly) linker (Figure S1). We also determined the structures
of VcDncV in the GTP- and 30-dATP-bound forms at 1.65 A˚
and 1.60 A˚ resolutions, respectively (Figure 1A). These three
structures of VcDncV are substantially identical (root-mean-
square [rms] deviation <0.57 A˚ for aligned Ca atoms). Thus,
we describe the structure of VcDncV in the GTP-bound form
unless otherwise stated. Furthermore, we determined the
structure of the Escherichia coli homolog of DncV (EcDncV,
residues 1–407), which contains the region corresponding to
the less-conserved region of VcDncV (residues 213–238) in
the 30-dGTP-bound form at 2.31 A˚ resolution (Figure 1B).
The phases were determined by the molecular replacement
method using the structure of VcDncV. The electron densities
around the less-conserved regions of VcDncV (residues 203–
215 and the adjacent GSG linker) and EcDncV (residues 201–
235 in EcDncV) were disordered. Despite the different crystal
packing between VcDncV and EcDncV, these structures are
essentially identical (rms deviation = 1.4 A˚ for 367 Ca atoms)reserved
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Figure 2. Structural Rigidity of the Spine and the Catalytic Loop in DncV
(A) Superimposition of the crystal structures between VcDncV (beige) and the mouse cGAS-DNA complex (gray) (PDB 4K96).
(B–D) Close-up views of the spine and catalytic loop in themouse cGAS apo form (PDB 4K8V) (B), themouse cGAS-DNA complex (PDB 4K96) (C) and VcDncV (D).
Double-stranded DNA is shown as a yellow ribbon. The spine and catalytic loop are colored blue and pink, respectively. The residues are shown as stick or
semitransparent space-filling models.(Figures 1A and 1B), indicating that the less-conserved regions
of both VcDncV and EcDncV are flexible and do not affect the
overall structure.
Overall Structure of DncV
DncV adopts an extended bilobed architecture characterized
by a nucleotidyltransferase fold (Figure 1A). The bilobed archi-
tecture consists of an N-terminal a/b core and a C-terminal helix
bundle, which are stabilized by the spine, composed of one long
a helix and two short a helices. The a/b core contains five helices
located on one side and a centrally twisted eight-stranded b
sheet. The C-terminal helix bundle consists of eight helices
and one pair of anti-parallel b sheets. The deep catalytic pocket
exists between the a/b core and the helix bundle and
the catalytic loop (residues 112–129) is located at the bottom
of the pocket. The catalytic triad of the nucleotidyl transferase
family (Asp131, Asp133, and Asp193) is located on the b sheet
in the a/b core and two magnesium ions and two nucleotides
are bound to the active site. These structural features are also
observed in the structure of EcDncV (Figure 1B), highlighting
their functional significance. Despite the low sequence identity
(<10%), DncV is structurally similar to the human, mouse, and
porcine cGASs (Figure 2A, rms deviation values = 2.9–3.2 A˚
for 227–251 Ca atoms) (Civril et al., 2013; Gao et al., 2013;
Kato et al., 2013; Kranzusch et al., 2013; Li et al., 2013; Zhang
et al., 2014).
Mammalian cGAS can produce 20–50 cGAMP only in the pres-
ence of DNA (Ablasser et al., 2013; Sun et al., 2013), whereas
DncV is a constitutively active protein and produces 30–50
cGAMP even in the absence of DNA (Davies et al., 2012; Diner
et al., 2013). These distinct activation mechanisms were pre-
viously explained based on the structural differences in the
arrangement of the catalytic triad, as well as the regulatory
loop, which is missing in DncV (Kranzusch et al., 2014). In addi-
tion to these structural characteristics, we should mention the
other structural differences between DncV and cGAS, which
are important for the constitutive activity of DncV. MammalianStructure 23cGAS requires a structural rearrangement for the activation
(Civril et al., 2013; Gao et al., 2013; Kato et al., 2013), in which
the leucine residue (Leu159 in mouse) on the spine helix moves
toward the core of the protein upon DNA binding, which in
turn rearranges the catalytic loop for the reaction (Figures 2B
and 2C). Although the corresponding leucine residue is also
conserved in DncV (Leu24 in V. cholerae), the residue is already
oriented toward the catalytic pocket and forms hydrophobic
interactions with Leu32, Leu120, and Met130, which stabilize
the catalytic loop even in the absence of bound DNA (Figure 2D).
Therefore, the spine of DncV is structurally similar to that of
mammalian cGAS in the active state, rather than that in the
inactive state (Figures 2B–2D). The catalytic loop of DncV is
also stabilized by a salt bridge between Arg122 on the catalytic
loop and Glu28 on the spine (Figure 2D) and does not undergo
a significant conformational change upon substrate binding.
These observations suggested that the catalytic loop of DncV
is rigid and contributes to the formation of the catalytic pocket,
even in the absence of DNA.
Nucleotide Recognition by the Donor
and Acceptor Pockets
In the GTP- and 30-dATP-bound structures of DncV, we
observed the electron densities of nucleotides in both the
acceptor and donor pockets (Figures 3A and S2A). The electron
densities of the donor nucleotide were well defined, while those
of the acceptor nucleotide, especially the b- and g-phosphate
groups, were relatively weak (Figure S2A). Thus, we were unable
to unambiguously assign the positions of the b- and g-phos-
phate groups of the acceptor nucleotide and excluded them
from the structural model. In the GTP-bound form, two Mg2+
ions are bound to the active site (Figure 3B, left panel, and
Figure S2B). One Mg2+ ion (M1) is coordinated by Asp131,
Asp133, the phosphate moiety of the donor nucleotide,
and one water molecule in an octahedral coordination. The
other Mg2+ ion (M2) is coordinated by the 30-OH group of
the acceptor nucleotide, Asp131, the a-phosphate group of, 843–850, May 5, 2015 ª2015 Elsevier Ltd All rights reserved 845
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Figure 3. Nucleotide Recognition by DncV and cGAS in the Pre-reaction State
(A) Molecular surfaces of VcDncV in the GTP-bound form (left panel), VcDncV in the 30-dATP-bound form (middle panel), and the porcine cGAS-DNA-GTP-ATP
complex (PDB 4KB6, right panel). The bound acceptor and donor nucleotides are shown as light green and yellow stick models, respectively. The magnesium
ions are shown as gray spheres.
(B and C) Two alternate views of the interactions between the nucleotides and the catalytic pocket in VcDncV in the GTP-bound form (left panel), VcDncV in the
30-dATP-bound form (middle panel), and the porcine cGAS-DNA-GTP-ATP complex (right panel). The bound nucleotides and magnesium ions are shown with
the same representations as in (A). The interacting residues are shown as stick or semitransparent space-filling models.the donor nucleotide, and threewater molecules in an octahedral
coordination. In the 30-dATP-bound form, the Mg2+ ion in the M1
site was clearly observed and is coordinated in a manner similar
to that in the GTP-bound form, while no Mg2+ ion was observed
in the M2 site (Figure S2B). In both the GTP- and 30-dATP-bound
structures, the acceptor and donor nucleotides were not linked
via a phosphodiester bond (Figures 3A and S2A), suggesting
that these structures represent the pre-reaction state.
In the pre-reaction state, the donor pocket of DncV recognizes
both GTP and 30-dATP in a similar manner (Figures 3A and 3B). In
the GTP-bound form, the nucleotide in the donor pocket adopts
an anti conformation (c torsion angle = 172), with the N1 and
N2 atoms of its base moiety forming bidentate hydrogen bonds
with Asp348 (Figure 3B, left panel). In addition, the base moiety
forms van der Waals interactions with the side chains of Val264
and Ile302. The 30-OH group hydrogen bonds with the side chain846 Structure 23, 843–850, May 5, 2015 ª2015 Elsevier Ltd All rightsof Tyr117. The triphosphate moiety hydrogen bonds with Ser114
and Tyr117 on the catalytic loop, as well as Lys287 and Ser301
on the helix bundle (Figure 3B, left panel). In the 30-dATP-bound
form, the donor nucleotide also adopts an anti conformation
(c = 164) and the phosphate and ribose moieties are recog-
nized in a similar manner to those in the GTP-bound form (Fig-
ure 3B, middle panel). However, the adenine base is recognized
through only one water-mediated hydrogen bond, between the
N1 atom and Asp348 (Figure 3B, middle panel). These observa-
tions suggested the possibility that the donor pocket recognizes
GTP with higher affinity than ATP and thereby favors GTP as the
donor nucleotide.
In contrast, the acceptor pocket of DncV recognizes GTP
and 30-dATP in a distinctive manner. The acceptor nucleotide
adopts an anti conformation (c = 129) in the GTP-bound
form (Figure 3C, left panel), whereas it adopts a syn conformationreserved
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Figure 4. Structural Superposition of the
Bound Nucleotides between GTP and ATP
Superposition between the structures of VcDncV
in the GTP-bound form and the ATP-bound form
modeled by the 3’-dATP-bound form. GTP and
ATP are shown as light pink and light blue sticks,
respectively. In this model, the 30-OH group of ATP is
close to the a-phosphate of the donor nucleotide,
with suitable geometry for the inline attack on the
phosphorus atom.(c = 7.34) in the 30-dATP-bound form (Figure 3C, middle
panel). The N1 atom of GTP directly hydrogen bonds with the
side chain of Ser259 and the N2 atom directly hydrogen bonds
with the main chain of Ser259 and the side chain of Tyr197 (Fig-
ure 3C, left panel). In contrast, the N6 atom of 30-dATP directly
hydrogen bonds with the side chain of Ser259 and the N7
atom forms a water-mediated hydrogen bond with the main
chain of Ser259 and the side chain of Tyr197, reinforcing the
syn conformation of the acceptor 30-dATP (Figure 3C, middle
panel). These observations suggested the possibility that the
acceptor pocket also recognizes GTP with higher affinity than
ATP. We also determined the complex structure of VcDncV
with 30-dGTP and compared its structure with the GTP-bound
form (Figures S2C and S3). The result showed that 30-dGTP is
bound to the acceptor pocket in almost the same manner as
GTP, suggesting that there is almost no impact of the deoxy
NTP on the alignment of the substrate in the acceptor pocket.
In the present crystal structure of the GTP-bound form, the
30-OH group of the acceptor GTP is proximal to the catalytic
Asp193 residue and the a-phosphate group of the donor nucle-
otide (Figures 3B and 3C, left and middle panels). The distance
between the 30-OH group of the acceptor GTP and the Asp193
carboxylate oxygen is 2.8 A˚, which is closer than the distance
from the 20-OH group (4.6 A˚). The distance between the 30-OH
group of the acceptor GTP and the a-phosphate group of
the donor nucleotide is 4.4 A˚, and thus they are closer than the
distance from the 20-OH group (5.0 A˚) (Figures 3B and 3C, left
panels). This observation suggested that the 30-OH of the
acceptor nucleotide, rather than the 20-OH, is placed in a suitable
position for the nucleophilic attack to the a-phosphorus atom
of the donor nucleotide. Therefore, DncV catalyzes 30–50 phos-
phodiester formation in the first step of the reaction.
Nucleotide Binding Mode and Product Specificity
of DncV
Previous biochemical studies showed that DncV can synthesize
three different CDNs, i.e., cyclic di-GMP, cyclic di-AMP, and
30–50 cGAMP (Davies et al., 2012; Diner et al., 2013). The present
crystal structures of the GTP- and 30-dATP-bound forms sug-
gested that the ribose and triphosphate moieties of both GTP
and ATP are bound to the donor and acceptor pockets in a
similar manner. This explains why DncV can produce all of these
CDNs. However, it was also shown that DncV predominantly
produces 30–50 cGAMP in the presence of both ATP and GTP,
including physiological conditions (Davies et al., 2012; DinerStructure 23et al., 2013). This result is seemingly paradoxical, because the
present crystal structures suggested that both the donor and
acceptor pockets have higher affinity for GTP (Figures 3B and
3C). Thus, these apparently contradictory observations raise
the question of what defines the preference of the acceptor
pocket for ATP.
In our structure of the GTP-bound form, both the acceptor and
donor pockets were occupied with GTPs. The location of the
30-OH group of the acceptor nucleotide is proximal to the
a-phosphate group of the donor nucleotide (4.4 A˚) but the angle
between 30-OH and the a-phosphorus atom is not optimal for
the inline nucleophilic attack (Figure 4). This suggests that
the energy barrier for the transition-state formation is high and
thus DncV is trapped in the pre-reaction state in the crystal struc-
ture (Figure 3, left panel). In contrast, when DncV was co-crystal-
lized with ATP, the electron density corresponding to pyrophos-
phate, but not the nucleotide, was observed in the crystal
(Figure S2D). This result suggests that the energy barrier in the
ATP-bound form is low and thus the nucleotidyl transfer reaction
occurred before and/or after the crystallization. Therefore, it is
likely that DncV efficiently catalyzes the phosphodiester linkage
formation with ATP bound to the acceptor pocket, compared
with GTP, thereby producing pppA(30–50)pG preferentially. This
assumption is consistent with the recent biochemical data indi-
cating that DncV recognizes GTP and ATP as the donor and
acceptor nucleotide, respectively (Kranzusch et al., 2014). To
further explore the differences in the catalytic efficiencies be-
tween GTP and ATP in the acceptor pocket, we modeled ATP
bound to the acceptor pocket, based on the 30-dATP-bound
crystal structure. Although the electron densities corresponding
to 30-dATP areweak (Figure S2A), themodel structure suggested
the possibility that the ribosemoiety of ATP binds to the acceptor
pocket in a different manner from that of GTP, and its 30-OH
group is located near the a-phosphate of the donor nucleotide
(3.6 A˚) with suitable geometry for the inline attack on the phos-
phorus atom (Figure 4). This difference stems from the distinct
binding modes of the adenine and guanine bases, i.e., the syn
and anti conformations, to the acceptor pocket in the crystal
structures (Figures 3C and 4). Taken together, although the
acceptor pocket of DncV can recognize both the guanine and
adenine bases of ATP and GTP, the distinct binding modes be-
tween their nucleobases result in the higher catalytic efficiency
with ATP (Figure 4). Since the nucleotide coordination indicates
that the donor pocket has higher affinity for GTP, this difference
may result in the preferential synthesis of pppA(30–50)pG as the, 843–850, May 5, 2015 ª2015 Elsevier Ltd All rights reserved 847
Figure 5. Superposition of the Acceptor GTP between VcDncV
and Porcine cGAS in the Pre-reaction States
The acceptor GTP and Arg353 in porcine cGAS are shown as orange stick
models. The acceptor GTP and Ile257 in VcDncV are shown as silver stick
models. The phosphorus atom of the acceptor ATP in porcine cGAS is shown
as a yellow sphere.intermediate product and finally lead to the predominant pro-
duction of 30–50 cGAMP in the presence of both ATP and GTP
(Figure S4A).
Linkage Specificity in the Nucleotidyl Transfer Reaction
In the first nucleotidyl transfer reaction, cGAS catalyzes the
20–50 phosphodiester linkage, whereas DncV catalyzes the
30–50 phosphodiester linkage (Figure S4). A previous study
suggested the importance of Arg376 of human cGAS (corre-
sponding to Arg353 of porcine cGAS and Ile257 of VcDncV) for
this difference in the linkage specificity, based on the structural
comparison between DncV and cGAS in the intermediate state
(Kranzusch et al., 2014). Furthermore, the importance of this
site was exemplified by the fact that the R376I mutant of human
cGAS produces 30–50 cGAMP (Kranzusch et al., 2014). However,
the distinct linkage specificity between DncV and cGAS is
defined in the pre-reaction state. A structural comparison of
the pre-reaction states of the first reaction step provides a
more direct explanation for the precise mechanism that defines
the linkage specificity (Figure 3).
In the porcine cGAS structure in the pre-reaction state (Civril
et al., 2013; PDB ID 4KB6), the side chain guanidinium group
of Arg353 (Arg376 in human) interacts with the N7 atom of the
guanine base of the acceptor GTP. The structural superposition
of the present crystal structure of VcDncV in the GTP-bound
form and porcine cGAS suggested the possibility that this
guanidinium group of Arg353 in cGAS clashes with the O6
atom of the guanine base of the acceptor GTP in DncV (Figure 5).
Therefore, in cGAS, the interaction with the Arg353 side chain
pushes the nucleobase of the acceptor GTP into the acceptor
pocket, which changes the binding mode of the acceptor
nucleotide and places the 20-OH group of the ribose moiety in
a position suitable for the nucleophilic attack (Figures 3C
and 5). In contrast, in the R376I mutant of human cGAS, the small848 Structure 23, 843–850, May 5, 2015 ª2015 Elsevier Ltd All rightsside chain of Ile376 may allow the binding of the acceptor nucle-
obase in a similar manner to that in DncV (Figures 3C and 5)
and thus the mutant exhibited 30–50 cGAMP formation activity
(Kranzusch et al., 2014). However, it should be noted here that
the similar mutation of DncV (I257R), which was expected to
change its nucleotide binding mode to that of cGAS, did not
result in 20–50 cGAMP formation activity (Kranzusch et al.,
2014). Why was the orientation of the acceptor nucleotide not
affected by the I257R mutation in DncV to change the linkage
specificity? This question can be answered by considering the
structural differences around Arg376 in cGAS and Ile257 in
DncV (Figure S5). In porcine cGAS, Arg353 (corresponding to
Arg376 in human) is surrounded by residues with bulky side
chains, including His223, on the additional b strands, and the
side chain orientation of the arginine residue is fixed toward
the acceptor nucleobase (Figure S5B). In contrast, these b
strands aremissing in DncV, and Ile257 is exposed to the solvent
(Figure S5A). Therefore, it is likely that the side chain of Arg257 in
the DncV I257R mutant is not fixed in the position close to the
acceptor nucleotide, as in the case of cGAS, and thus failed to
affect the orientation of the acceptor nucleotide. Along with
Arg376, the additional b strands around the catalytic pocket
are also important for the 20–50 specific phosphodiester linkage
formation in cGAS.
Concluding Remarks
Our structures of VcDncV provided the structural basis for the
bacteria-specific mechanism of CDN production, along with
the previously reported crystal structures of DncV in different
states (Figure S4). Furthermore, our structures of both VcDncV
and EcDncV suggested that the DncVs from other bacterial spe-
cies also produce bacteria-specific CDNs in a similar manner.
Thus, the present crystal structures pave the way for the rational
design of new antibacterial drugs targeting DncV, which could
affect a broad spectrum of pathogenic bacteria.
EXPERIMENTAL PROCEDURES
Protein Preparation
The gene encoding full-length VcDncV (UniProt number: Q9KVG7) was syn-
thesized with codon optimization for protein expression in E. coli and cloned
into a modified pE-SUMO vector (LifeSensors) for expression of DncV as an
N-terminal His6-SUMO fusion protein. To obtain a suitable construct for
crystallization, the internal residues (216–241) were replaced by three amino
acid residues (Gly-Ser-Gly), in addition to the C-terminal truncation (residues
413–436). E. coli Rosetta2 (DE3) cells (Novagen) were transformed with the
expression vector and cultured at 37C in lysogeny broth medium to an
OD600 of 0.5–0.8. Isopropyl-b-D-thiogalactopyranoside was added to a
final concentration of 0.5 mM and the culture was continued for 16 hr at
18C. The cells were lysed in lysis buffer (50 mM Tris-HCl [pH 8.0], 300 mM
NaCl, 20mM imidazole, 5% glycerol, 2mMMgCl2, 1mMphenylmethylsulfonyl
fluoride, and 3 mM 2-mercaptoethanol) by sonication. The supernatants
were passed through an Ni-NTA (Qiagen) column and the resin was
washed with wash buffer (50 mM Tris-HCl [pH 8.0], 300 mM NaCl, 20 mM
imidazole, and 3 mM 2-mercaptoethanol). The bound proteins were eluted
by wash buffer supplemented with 300 mM imidazole. The eluted proteins
were dialyzed against wash buffer with Ulp1 to cleave the His6-SUMO tag.
The sample was further purified by chromatography on Ni-NTA, HiTrap
Heparin (GE Healthcare), and Superdex200 columns (GE Healthcare).
The selenomethionine (SeMet)-labeled VcDncV protein was overexpressed
in E. coli B834 (DE3) cells and purified using the same protocol as that for
the native protein.reserved
Table 1. Data Collection and Refinement Statistics
VcDncV apo (SeMet) VcDncV GTP VcDncV 30-dATP VcDncV 30-dGTP EcDncV 30-dGTP
Data Collection
Space group C2 C2 C2 C2 C2
Cell dimensions
a, b, c (A˚) 119.0, 50.74, 73.07 118.8, 49.85, 72.86 118.0, 51.30, 71.54 118.0, 50.06, 72.27 136.1, 46.30, 62.57
a, b, g () 90.0, 93.1, 90.0 90.0, 93.5, 90.0 90.0, 93.9, 90.0 90.0, 93.4, 90.0 90.0, 110.6, 90.0
Resolution (A˚) 50.0–1.77 (1.80–1.77)a 50.0–1.65 (1.75–1.65)a 50.0–1.60 (1.69–1.60)a 50.0–1.55 (1.65–1.55)a 50.0–2.31 (2.45–2.31)a
Rsym 0.114 (0.630) 0.084 (0.495) 0.033 (0.302) 0.039 (0.557) 0.126 (0.597)
I/sI 60.0 (5.28) 10.2 (2.67) 18.8 (3.29) 17.6 (2.12) 11.6 (2.48)
Completeness (%) 99.3 (98.4) 97.2 (89.3) 97.5 (92.1) 98.5 (94.1) 99.5 (98.9)
Redundancy 15.3 (14.8) 3.8 (3.6) 3.4 (3.2) 3.6 (3.2) 3.7 (3.7)
Refinement
Resolution (A˚) 47.3–1.77 (1.83–1.77) 46.0–1.65 (1.71–1.65) 47.0–1.60 (1.65–1.60) 47.0–1.55 (1.58–1.55) 37.1–2.31 (2.39–2.31)
No. reflections 82,517 49,988 55,529 60,174 16,217
Rwork/Rfree 0.180/0.204 0.174/0.206 0.169/0.195 0.175/0.193 0.189/0.234
No. of atoms
Protein 2,924 2,938 2,987 2,968 3,003
Ligand/ion 16 102 81 95 56
Water 233 263 280 240 100
B factors
Protein 34.8 25.9 30.8 30.5 32.5
Ligand/ion 45.5 41.5 58.6 35.7 28.7
Water 36.5 32.3 37.8 38.5 33.7
Rms deviations
Bond lengths (A˚) 0.010 0.009 0.006 0.012 0.003
Bond angles () 1.137 1.224 1.074 1.338 0.669
aThe values in parentheses are for the highest-resolution shell.A codon-optimized gene encoding full-length EcDncV (UniProt number:
Q6XGD8) was synthesized and the C-terminal residues (residues 408–432)
were deleted. The EcDncV protein was cloned, expressed, and purified using
the same protocol as that for the VcDncV protein.
Crystallization
The purified proteins were concentrated to 10 mg ml1 using an Amicon
Ultra filter (Millipore). All crystallization experiments were performed at 20C.
The crystals of the native and SeMet-labeled VcDncV apo form were obtained
under conditions containing 18%–22% PEG3350, 0.2 M NaF and 0.1 M
Bis-Tris propane (pH 6.5). The crystals of VcDncV in the GTP-bound form
were obtained by the soaking method using 10 mM MgCl2 and 10 mM GTP.
The crystals of VcDncV in the 30-dATP-bound form were obtained by co-crys-
tallization with 10 mMMgCl2 and 10 mM 3
0-dATP under conditions containing
20% PEG3350, 0.2 M sodium malonate, and 0.1 M Tris-HCl (pH 8.0). The
crystals of EcDncV in the 30-dGTP-bound form were obtained by co-crystalli-
zation with 10 mMMgCl2, 2.5 mM 3
0-dGTP, and 2.5 mM ATP under conditions
containing 25% PEG3350, 0.2 M NaCl, and 0.1 M Bis-Tris propane (pH 5.5).
Data Collection, Structure Determination, and Refinement
Crystals were cryoprotected in crystallization buffer supplemented with
20% ethylene glycol for VcDncV and 20% glycerol for EcDncV, respectively.
X-Ray diffraction data were collected on beamline BL41XU at SPring-8
(Hyogo, Japan) and BL-5A at the Photon Factory (Tsukuba, Japan). Data
were processed and scaled with the HKL2000 program package (HKL
Research Inc.) or XDS (Kabsch, 2010). The structure of the VcDncV apo
form was determined by the single-wavelength anomalous diffraction method,
using the SeMet-labeled crystal. Thirteen Se atoms were located using
SHELXD (Sheldrick, 2008). The phasing and density modification wereStructure 23performed with autoSHARP (Vonrhein et al., 2007), followed by automated
model building using PHENIX AutoBuild (Terwilliger et al., 2008). All nucleotide
complex structures were solved by the molecular replacement method with
MOLREP (Vagin and Teplyakov, 2010), using the structure of the VcDncV
apo form as a search model. Model building and refinement were performed
using COOT (Emsley and Cowtan, 2004) and PHENIX (Adams et al., 2010),
respectively. Data collection and refinement statistics are summarized in
Table 1.
ACCESSION NUMBERS
The atomic coordinates and structure factors of DncV have been deposited in
the PDB: ID codes 4XJ1 (VcDncV apo form), 4XJ3 (VcDncV GTP-bound form),
4XJ4 (VcDncV 30-dATP-bound form), 4XJ5 (VcDncV 30-dGTP-bound form),
4XJ6 (EcDncV 30-dGTP-bound form).
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